Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-823778 in Overweight and Obese Subjects With Hypertension
NCT01602367Phase 2Terminated
- Sponsor
- Bristol Myers Squibb
- Start
- Jul 2012
- Primary completion
- Nov 2012
- Countries
- 5
01
Overview
A Phase 2 trial of bms-823778 in hypertension (HTN), sponsored by Bristol Myers Squibb. Started Jul 2012; status: terminated.
02
Drugs
bms-823778
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01602367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01602367.